Skip to Content

Sprycel Prices, Coupons and Patient Assistance Programs

Sprycel (dasatinib) is a member of the BCR-ABL tyrosine kinase inhibitors drug class and is commonly used for Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia and Leukemia.

Sprycel Prices

This Sprycel price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Sprycel oral tablet 20 mg is around $7,487 for a supply of 60 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

A generic version of Sprycel has been approved by the FDA. However we either do not have pricing information for it, or it is not commercially available. More info: generic Sprycel availability

Oral Tablet

20 mg Sprycel oral tablet
from $7,487.38 for 60 tablet
Quantity Per unit Price
60 $124.79 $7,487.38

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

50 mg Sprycel oral tablet
from $14,966.68 for 60 tablet
Quantity Per unit Price
60 $249.44 $14,966.68

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

70 mg Sprycel oral tablet
from $14,966.68 for 60 tablet
Quantity Per unit Price
60 $249.44 $14,966.68

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

80 mg Sprycel oral tablet
from $13,488.26 for 30 tablet
Quantity Per unit Price
30 $449.61 $13,488.26

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

100 mg Sprycel oral tablet
from $13,488.26 for 30 tablet
Quantity Per unit Price
30 $449.61 $13,488.26

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

140 mg Sprycel oral tablet
from $13,488.26 for 30 tablet
Quantity Per unit Price
30 $449.61 $13,488.26

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.


Sprycel Coupons and Rebates

Sprycel offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Sprycel One Card: New Cash-Paying/Medicaid/Medicare Patients - Eligible patients may receive a 1-month FREE trial supply; for additional information contact the program at 855-777-9235.

Applies to:Sprycel
Number of uses:One-time offer
ExpiresDecember 31, 2019

Sprycel One Card: Eligible patients may pay no more than $0 per month on each of up to 12 prescriptions within 1 calendar year with savings of up to a maximum of $32,000 per year; for additional information contact the program at 855-777-9235.

Applies to:Sprycel
Number of uses:12 times within calendar year
ExpiresDecember 31, 2019

Patient Assistance Programs for Sprycel

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: HealthWell Foundation Copay Program

Elligibility requirements:

  1. May have insurance
  2. Varies
  3. Medically appropriate condition/diagnosis
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.

Applicable drugs:

  • Sprycel (dasatinib)

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Sprycel (dasatinib)

Provider: BMS Access Support for Oncology

Elligibility requirements:

  1. Must have no prescription coverage for needed medication
  2. At or below 300% of FPL
  3. FDA-approved diagnosis
  4. The patient must reside in the US, Puerto Rico or the USVI.
  5. This program is intended for US HEALTHCARE PROFESSIONALS and/or Professionals involved in Healthcare Reimbursement ONLY. Medicare Part D enrollees may apply for assistance through a case by case appeals process based on significant financial and medical need. Those receiving Medicare Part D LIS are not eligible. Contact program for details. *This program provides the screening for the Bristol-Myers Squibb Patient Assistance Foundation (BMSPAF) Oncology Patient Assistance Program. This program also provides copay assistance.

Applicable drugs:

  • Sprycel (dasatinib)

Provider: Good Days Program

Elligibility requirements:

  1. Not specified
  2. Not disclosed
  3. Not specified
  4. US residency requirements are not specified.
  5. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.

Applicable drugs:

  • Sprycel (dasatinib)
Hide